Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.34 |
| ▸ | NAAA | Q02083 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8771858 | 0.89 | THRB (0.37) | TSHRTHRBALDH1A1 | |
| SCHEMBL7051658 | 0.89 | TSHR (0.56) | TSHRTHRBNAAAALDH1A1HCAR2 | |
| SCHEMBL2831599 | 0.87 | TSHR (0.41) | TSHRTHRBTBXAS1NAAAPOLB | |
| SCHEMBL8773672 | 0.86 | TSHR (0.51) | TSHRTHRBTDP1ALDH1A1 | |
| SCHEMBL17813263 | 0.85 | TSHR (0.42) | TSHRTHRBNAAAHPGDALDH1A1 | |
| SCHEMBL6363350 | 0.84 | TSHR (0.38) | TSHRTHRBTBXAS1POLBAPEX1 | |
| SCHEMBL9646938 | 0.84 | TSHR (0.55) | TSHRTHRBNAAAPOLBAPEX1 | |
| SCHEMBL19456885 | 0.84 | TSHR (0.50) | TSHRTHRBNAAAPOLBAPEX1 | |
| SCHEMBL6547122 | 0.83 | TSHR (0.56) | TSHRTHRBTBXAS1POLBAPEX1 | |
| Vinyl Chloride SCHEMBL11773294 | 0.82 | TSHR (0.49) | TSHRNAAAHPGDALDH1A1HCAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2171047-A1 | REMOVAL OF BY-PRODUCTS FROM CROSSLINKABLE PREPARATIONS | Henkel AG & Co. KGaA (DE) | 2010-04-07 | — | — | EP | claimed |
| WO-2009013093-A1 | REMOVAL OF BY-PRODUCTS FROM CROSSLINKABLE PREPARATIONS | HENKEL AG & CO. KGAA (DE) | 2009-01-29 | — | — | WO | claimed |
| US-6981446-B2 | Ink-jet imaging method | EASTMAN KODAK COMPANY (US) | 2006-01-03 | — | — | US | claimed |
| US-20050005795-A1 | Ink-jet imaging method | CITICORP NORTH AMERICA, INC., AS AGENT | 2005-01-13 | — | — | US | claimed |
| WO-2023004044-A2 | COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES BY INHIBITING FSH | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) | 2023-01-26 | — | — | WO | disclosed |
| US-20220211768-A1 | CONDITIONED MEDIUM AND METHODS OF USE THEREOF | ALLERGAN SALES, LLC | 2022-07-07 | — | — | US | disclosed |
| US-20220204921-A1 | CONDITIONED MEDIUM AND EXTRACELLULAR MATRIX COMPOSITIONS FROM CELLS CULTURED UNDER HYPOXIC CONDITIONS | HISTOGEN INC (US) | 2022-06-30 | — | — | US | disclosed |
| US-20220031760-A1 | COMPOSITIONS AND METHODS FOR REDUCING INFLAMMATION | ALLERGAN SALES, LLC | 2022-02-03 | — | — | US | disclosed |
| US-11191780-B2 | Extracellular matrix compositions for the treatment of cancer or immunological diseases | ADAPTIVE BIOLOGIX, INC. (US) | 2021-12-07 | — | — | US | disclosed |
| US-20210299036-A1 | CONDITIONED MEDIUM AND EXTRACELLULAR MATRIX COMPOSITIONS AND USES THEREOF | ALLERGAN SALES, LLC | 2021-09-30 | — | — | US | disclosed |
| WO-2021163429-A1 | CONDITIONED MEDIUM FROM CELLS CULTURED UNDER HYPOXIC CONDITIONS AND USES THEREOF | ALLERGAN SALES, LLC (US) | 2021-08-19 | — | — | WO | disclosed |
| US-20210254008-A1 | CONDITIONED MEDIUM FROM CELLS CULTURED UNDER HYPOXIC CONDITIONS AND USES THEREOF | ALLERGAN SALES, LLC | 2021-08-19 | — | — | US | disclosed |
| EP-1237547-A2 | COMPOUNDS FOR INHIBITING DISEASES AND PREPARING CELLS FOR TRANSPLANTATION | ISIS INNOVATION LIMITED (GB) | 2002-09-11 | — | — | EP | disclosed |
| EP-1015244-B1 | PROCESSLESS, LASER IMAGEABLE LITHOGRAPHIC PRINTING PLATE | KODAK POLYCHROME GRAPHICS CO (US) | 2002-03-13 | — | — | EP | disclosed |
| US-6261740-B1 | Processless, laser imageable lithographic printing plate | KODAK POLYCHROME GRAPHICS, LLC | 2001-07-17 | — | — | US | disclosed |
| WO-2001003680-A2 | COMPOUNDS FOR INHIBITING DISEASES AND PREPARING CELLS FOR TRANSPLANTATION | ISIS INNOVATION LIMITED (GB) | 2001-01-18 | — | — | WO | disclosed |
| EP-1029668-A2 | Processless, laser imageable lithographic printing plate | Kodak Polychrome Graphics Company Ltd. (US) | 2000-08-23 | — | — | EP | disclosed |
| EP-1015244-A1 | PROCESSLESS, LASER IMAGEABLE LITHOGRAPHIC PRINTING PLATE | Kodak Polychrome Graphics (US) | 2000-07-05 | — | — | EP | disclosed |
| US-5919601-A | COMPRISING THERMAL-ACTIVATED ACID GENERATOR, CROSSLINKING RESIN, BINDER RESIN CONTAINING PENDANT GROUPS CAPABLE OF UNDERGOING ACID-CATALYZED CONDENSATION WITH CROSSLINKING RESIN, INFRARED ABSORBER | KODAK POLYCHROME GRAPHICS, LLC (US) | 1999-07-06 | — | — | US | disclosed |
| WO-1999011457-A1 | PROCESSLESS, LASER IMAGEABLE LITHOGRAPHIC PRINTING PLATE | KODAK POLYCHROME GRAPHICS LLC (US) | 1999-03-11 | — | — | WO | disclosed |